Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
877.35
-22.50 (-2.50%)
Mar 12, 2025, 9:30 AM IST
Zydus Lifesciences Revenue
Zydus Lifesciences had revenue of 52.69B INR in the quarter ending December 31, 2024, with 16.96% growth. This brings the company's revenue in the last twelve months to 222.47B, up 16.94% year-over-year. In the fiscal year ending March 31, 2024, Zydus Lifesciences had annual revenue of 195.47B with 13.40% growth.
Revenue (ttm)
222.47B
Revenue Growth
+16.94%
P/S Ratio
4.07
Revenue / Employee
8.26M
Employees
26,921
Market Cap
905.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 195.47B | 23.10B | 13.40% |
Mar 31, 2023 | 172.37B | 21.28B | 14.08% |
Mar 31, 2022 | 151.10B | 7.06B | 4.90% |
Mar 31, 2021 | 144.04B | 1.50B | 1.06% |
Mar 31, 2020 | 142.53B | 10.88B | 8.26% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Fortis Healthcare | 75.61B |
Zydus Lifesciences News
- 2 days ago - Zydus gets USFDA final approval for Ketoconazole Shampoo, 2% - Business Upturn
- 6 days ago - Zydus Lifesciences shares surge over 4% after USFDA approval for generic Dasatinib tablets - Business Upturn
- 6 days ago - Stocks to watch today, March 6: Zydus Lifesciences, Castrol India, TCS, Wipro, Ola Electric and more - Business Upturn
- 6 days ago - Zydus Lifesciences secures USFDA approval for Dasatinib Tablets - Business Upturn
- 7 days ago - Zydus Lifesciences launches ANVIMO for transplant patients - Business Upturn
- 7 days ago - Zydus To Develop Combination Vaccine For Shigellosis And Typhoid - NDTV
- 7 days ago - Zydus Lifesciences to develops world’s first shigellosis and typhoid combination vaccine - Business Upturn
- 17 days ago - Zydus gets USFDA nod for Ibuprofen and Famotidine tablets - Business Upturn